FdaApplication
NDA 215809
Identifiers
- fda_app_no: NDA215809
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2022-04-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERMEZA | LEVOTHYROXINE SODIUM | 150MCG/5ML | SOLUTION;ORAL |
1 product